Login
Evidence Feed
About
Conferences
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
APOBEC mutagenesis
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
VERI cancer hierarchy
x
x
x
x
Reset Filters
APOBEC mutagenesis
Urothelial Cancer
APOBEC mutagenesis
Urothelial Cancer
atezolizumab
Sensitive: B - Late Trials
atezolizumab
Sensitive
:
B
atezolizumab
Sensitive: B - Late Trials
atezolizumab
Sensitive
:
B
APOBEC mutagenesis
Urothelial Cancer
APOBEC mutagenesis
Urothelial Cancer
pembrolizumab
Sensitive: C3 – Early Trials
pembrolizumab
Sensitive
:
C3
pembrolizumab
Sensitive: C3 – Early Trials
pembrolizumab
Sensitive
:
C3
APOBEC mutagenesis
Urothelial Cancer
APOBEC mutagenesis
Urothelial Cancer
cisplatin
Resistant: C3 – Early Trials
cisplatin
Resistant
:
C3
cisplatin
Resistant: C3 – Early Trials
cisplatin
Resistant
:
C3
APOBEC mutagenesis
Urothelial Cancer
APOBEC mutagenesis
Urothelial Cancer
carboplatin
Resistant: C3 – Early Trials
carboplatin
Resistant
:
C3
carboplatin
Resistant: C3 – Early Trials
carboplatin
Resistant
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
